The report will be delivered in 2-3 business days.

HER2 Inhibitors Global Market Report 2021 - By Treatment (Monotherapy, Combination Therapy), By Application (Squamous Cell Carcinoma, Adenocarcinoma, Large Cell Carcinoma, Breast Cancer), By End User (Hospitals, Clinics), COVID-19 Growth And Change

Starting Price : $5000.00 | Pages : 175 | Published : March 2021 | SKU CODE : 7700 | Format :


The HER2 inhibitors market consists of sales of HER2 inhibitors and related services by entities (organizations, sole traders, and partnerships) that manufacture HER2 inhibitors. Human epidermal growth factor receptor (HER2) inhibitors slow down or stop cell growth thus reducing the risk for cancer growth.

The HER2 inhibitor market covered in this report is segmented by treatment into monotherapy, combination therapy; by application into squamous cell carcinoma, adenocarcinoma, large cell carcinoma, breast cancer, others; by end user into hospitals, clinics, others.

The global her2 inhibitors market is expected to grow from $5.98 billion in 2020 to $6.4 billion in 2021 at a compound annual growth rate (CAGR) of 7%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The HER2 inhibitors market is expected to reach $9.31 billion in 2025 at a CAGR of 10%.

The rise in the number of breast cancer cases across the globe is likely to contribute to the growth of the HER-2 inhibitors market during the forecast period. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. As of January 2020, there were more than 3.5 million women with a history of breast cancer in the US. This includes women currently being treated and women who have completed their treatment. According to the World Health Organization (WHO), 627,000 people died of breast cancer in 2018, which is about 15% of all women cancer deaths. Therefore, the rise in the breast cancer incidence rate globally is anticipated to boost the demand for the HER-2 inhibitors market over the forthcoming years.

High costs associated with the HER-2 inhibitors treatment is a major issue faced by citizens of many countries. The pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, the lack of cost-effective therapies for cancer has influenced the health conditions of the population and has led to a low average life expectancy. Trastuzumab, a licensed HER2 inhibitor, has been the most expensive systemic cancer therapy procedure at a variety of disease sites. In 2019, the cost of trastuzumab in India ranged from $774.6 to $841.35 per 440 mg vial. In patients with HER 2 positive early breast cancer, nearly 18 cycles of therapy based on trastuzumab are needed that further charge more than $1,335.52 in India. Therefore, the high cost of HER2 inhibitors is expected to hinder the growth of the HER2 inhibitors market.

Biotechnology companies are focusing on acquiring or partnering with biopharmaceutical companies to develop and promote the HER-2 inhibitors market. There have been several partnerships in recent years which help these companies to increase their HER-2 inhibitors portfolio, enhance their revenues and share the costs. For instance, in June 2020, Alphamab Oncology, a biotechnology company, collaborated with Sanofi, a pharmaceutical company, for investigating KN026 in combination with other drugs for the treatment of HER2 breast cancer. KN026 is a HER2 inhibitor developed by Alphamab Oncology. In 2019, Daiichi Sankyo announced its collaboration with AstraZeneca for development and commercialization collaboration for Daiichi Sankyo’s HER2 targeting antibody drug conjugate.

In March 2018, Seattle Genetics announced its decision to acquire Cascadian Therapeutics for $614 million. The acquisition is expected to positively impact Seattle Genetic's product portfolio and boost its late-stage cancer drug pipeline. Cascadian Therapeutics is a US-based company that had developed an oral tyrosine kinase inhibitor, which is pivotal in mid-stage tests for advanced HER2 breast cancers. It is also slated for tests in other HER2 cancers such as colon cancer.

Major players in the HER2 inhibitors market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Boehringer-Ingelheim, Mylan, Biocon.

The regions covered in the HER2 inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the HER2 inhibitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global HER2 inhibitors market is segmented -

1) By Treatment: Monotherapy, Combination Therapy

2) By Application: Squamous Cell Carcinoma, Adenocarcinoma, Large Cell Carcinoma, Breast Cancer, Others

3) By End User: Hospitals, Clinics, Others

    Table Of Contents

    1. Executive Summary

    2. HER2 Inhibitors Market Characteristics

    3. HER2 Inhibitors Market Trends And Strategies

    4. Impact Of COVID-19 On HER2 Inhibitors

    5. HER2 Inhibitors Market Size And Growth

    5.1. Global HER2 Inhibitors Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global HER2 Inhibitors Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. HER2 Inhibitors Market Segmentation

    6.1. Global HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Monotherapy

    Combination Therapy

    6.2. Global HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Squamous Cell Carcinoma

    Adenocarcinoma

    Large Cell Carcinoma

    Breast Cancer

    Others

    6.3. Global HER2 Inhibitors Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospitals

    Clinics

    Others

    7. HER2 Inhibitors Market Regional And Country Analysis

    7.1. Global HER2 Inhibitors Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global HER2 Inhibitors Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific HER2 Inhibitors Market

    8.1. Asia-Pacific HER2 Inhibitors Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China HER2 Inhibitors Market

    9.1. China HER2 Inhibitors Market Overview

    9.2. China HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India HER2 Inhibitors Market

    10.1. India HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan HER2 Inhibitors Market

    11.1. Japan HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia HER2 Inhibitors Market

    12.1. Australia HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia HER2 Inhibitors Market

    13.1. Indonesia HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea HER2 Inhibitors Market

    14.1. South Korea HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe HER2 Inhibitors Market

    15.1. Western Europe HER2 Inhibitors Market Overview

    15.2. Western Europe HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK HER2 Inhibitors Market

    16.1. UK HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany HER2 Inhibitors Market

    17.1. Germany HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France HER2 Inhibitors Market

    18.4. France HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.5. France HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe HER2 Inhibitors Market

    19.1. Eastern Europe HER2 Inhibitors Market Overview

    19.2. Eastern Europe HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia HER2 Inhibitors Market

    20.1. Russia HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America HER2 Inhibitors Market

    21.1. North America HER2 Inhibitors Market Overview

    21.2. North America HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA HER2 Inhibitors Market

    22.1. USA HER2 Inhibitors Market Overview

    22.2. USA HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America HER2 Inhibitors Market

    23.1. South America HER2 Inhibitors Market Overview

    23.2. South America HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil HER2 Inhibitors Market

    24.1. Brazil HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East HER2 Inhibitors Market

    25.1. Middle East HER2 Inhibitors Market Overview

    25.2. Middle East HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa HER2 Inhibitors Market

    26.1. Africa HER2 Inhibitors Market Overview

    26.2. Africa HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. HER2 Inhibitors Market Competitive Landscape And Company Profiles

    27.1. HER2 Inhibitors Market Competitive Landscape

    27.2. HER2 Inhibitors Market Company Profiles

    27.2.1. F. Hoffmann-La Roche Ltd.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Merck & Co. Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Novartis AG

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Pfizer Inc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Puma Biotechnology Inc.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. HER2 Inhibitors Pipeline Analysis

    29. Key Mergers And Acquisitions In The HER2 Inhibitors Market

    30. HER2 Inhibitors Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global HER2 Inhibitors Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global HER2 Inhibitors Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global HER2 Inhibitors Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: China, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: China, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: India, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: India, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: Japan, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Japan, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Australia, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Australia, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Indonesia, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Indonesia, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: South Korea, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: South Korea, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: Western Europe, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: Western Europe, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: UK, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: UK, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Germany, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Germany, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: France, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: France, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Russia, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: Russia, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: North America, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: North America, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: USA, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: USA, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: South America, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: South America, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: Brazil, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: Brazil, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Middle East, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Middle East, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Africa, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Africa, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 47: Merck & Co. Inc. Financial Performance
  • Table 48: Novartis AG Financial Performance
  • Table 49: Pfizer Inc. Financial Performance
  • Table 50: Puma Biotechnology Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global HER2 Inhibitors Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global HER2 Inhibitors Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global HER2 Inhibitors Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: China, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: China, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: India, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: India, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: Japan, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Japan, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Australia, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Australia, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Indonesia, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Indonesia, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: South Korea, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: South Korea, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: Western Europe, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: Western Europe, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: UK, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: UK, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Germany, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Germany, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: France, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: France, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Russia, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: Russia, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: North America, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: North America, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: USA, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: USA, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: South America, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: South America, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: Brazil, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: Brazil, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Middle East, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Middle East, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Africa, HER2 Inhibitors Market, Segmentation By Treatment, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Africa, HER2 Inhibitors Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 47: Merck & Co. Inc. Financial Performance
  • Figure 48: Novartis AG Financial Performance
  • Figure 49: Pfizer Inc. Financial Performance
  • Figure 50: Puma Biotechnology Inc. Financial Performance
Global Psoriasis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Psoriatic Arthritis Treatment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Regenerative Medicine For Cartilage Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Radiopharmaceuticals Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Remdesivir Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Research Antibodies and Reagents Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Rituximab Biosimilars Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Respiratory Diseases Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Checkpoint Inhibitors Global Market Report 2021 - By Drug (PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4, Chimeric Antigen Receptor T-cell), By Application (Lung Cancer, Renal Cancer, Blood Cancer, Bladder Cancer, Melanoma), By End-Users (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Growth And Change
View Report
TNF Alpha Inhibitors Global Market Report 2021 - By Drug (Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab), By Route Of Administration (Oral, Subcutaneous, Intravenous), By Disease Type (Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis), COVID-19 Growth And Change
View Report
Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2021 - By Drugs Type (Avastin, Tecentriq, Cometriq, Eylea), By Route Of Administration (Oral, Intravenous), By Application (Oncology, Ophthalmology), COVID-19 Growth And Change
View Report
Interleukin Inhibitors Global Market Report 2021 - By Type (IL-17, IL-23, IL-1, IL-5, IL-6), By Application (Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Growth And Change
View Report
Immunosuppressants Global Market Report 2021 - By Drug Class (Corticosteroids, Monoclonal Antibodies (MAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents), By Indication (Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), COVID-19 Growth And Change
View Report
Antacids Global Market Report 2021 - By Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Formulation Type (Tablet, Liquid, Powder), COVID-19 Impact And Recovery
View Report
Protein Inhibitors Global Market Report 2021 - By Product (Protein Kinase Inhibitors, Monoclonal Antibody), By Application (Oncology, Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies), COVID-19 Growth And Change
View Report
Vascular Endothelial Growth Factor (VEGF) Inhibitor Market - By Drug Type (Eylea, Avastin, Tagrisso, Tecentriq, Others), By Route of Administration (Intravenous, Intravitreal, Oral), By Application (Oncology, Ophthalmology), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)